Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Tracking Antibiotic-Resistant Tuberculosis. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tracking Antibiotic-Resistant Tuberculosis (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 123 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart


Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership [The Lancet Infectious Diseases Web site]. June 2013;13(6):529-539. Available at: http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70030-6/fulltext Accessed August 16, 2018.
Ahuja SD, Ashkin D, Avendano M, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9153 patients. PLOS Med. August 28, 2012; 9(8) e1001300. Available at: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001300. Accessed August 16, 2018.
Barrera L. The basics of clinical bacteriology. In: Palomino JC, Leao SC, Ritacco V, eds. Tuberculosis 2007:From basic science to patient care. 1st ed. San Paulo: 93-112. Available at: http://www.pneumo-iasi.ro/student/tuberculosis2007.pdf. Accessed August 16, 2018.
Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Eng J Med. September 9, 2010; 363:1005-1015. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa0907847. Accessed August 16, 2018.
Cegielski P, Nunn P, Kurbatova, EV, et al. Challenges and controversies in defining totally drug-resistant tuberculosis. Centers for Disease Control and Prevention [Web site]. November 2012;18(11). Available at: http://wwwnc.cdc.gov/eid/article/18/11/12-0526_article.htm. Accessed August 16, 2018.
Centers for Disease Control and Prevention. Trends in tuberculosis—United States 2011. Morbity and Mortality Weekly Report (MMWR). March 23, 2012;61(11):181-185. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6111a2.htm. Accessed August 16, 2018.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2016. BCG vaccine. Available at: www.cdc.gov/tb/publications/factsheets/prevention/bcg.htm. Accessed August 16, 2018.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2017. The Costly Burden of Drug-Resistant TB in the U.S. 2017. Available at: https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/costly-burden-dr-tb-508.pdf Accessed September 4, 2018.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2016. Interferon-gamma release assays (IGRAs)- blood tests for TB infection. MMWR. 2010;59 (No.RR-5). Available at: www.cdc.gov/tb/publications/factsheets/testing/igra.htm. Accessed Auguat 16, 2018.
Filia A, Ciarrocchi G, Belfiglio R, et al. Tuberculosis in kindergarten and primary school, Italy, 2008-2009 [dispatch]. Centers for Disease Control and Prevention [Web site]. March 2011;17(3). Available at: http://wwwnc.cdc.gov/eid/article/17/3/10-1440_article.htm. Accessed August 16, 2018.
Fitzgerald D, Haas DW. Mycobacterium tuberculosis.In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Inc; 2005: 2861-2886.
Garfein RS, Laniado-Laborin R, Rodwell TC, et al. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico [research]. Centers for Disease Control and Prevention [Web site]. May 2010;16(5). Available at: http://wwwnc.cdc.gov/eid/article/16/5/09-1446_article.htm. Accessed August 16, 2018.
Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf?sequence=1. Accessed September 4, 2018.
Lin S-Y, Probert W, et al. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol. September 2004;42(9):4204. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC516347/. Accessed August 16, 2018.
McKinnon J. Budget cuts hit TB clinics at the border. Associated Press, California Health Report. April 2, 2012.
Migliori G, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany [letter]. Emerg Infect Dis. Centers for Disease Control and Prevention [Web site]. May 2007;13(5). Available at: http://wwwnc.cdc.gov/eid/article/13/5/07-0200_article.htm. Accessed August 16, 2018.
Parrish NM, Carroll KC. Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low -prevalence settings. Jour Clin Microbiol. March 2011;49(3): 772-776. Available at: http:="" www.ncbi.nlm.nih.="" gov="" pmc="" articles="" pmc3067741="" ?="" report="reader. Accessed August, 2018.
Pfyffer GE, Palicova F. Mycobacterium: General characteristics, laboratory detection, and staining procedures. In: Versalovic J, Carroll KC, Funke G, et al. Manual of Clinical Microbiology, 10th ed. Washington, DC: ASM Press; 2011: 472-502.
Phillips L. Infectious disease: TB’s revenge. Nature. January 2, 2013;493:14-16. Available at: http://www.nature.com/news/infectious-disease-tb-s-revenge-1.12115. Accessed August 16, 2018.
Pinon M, Scolfaro C, Bignamini E, et al. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics. November 1, 2010;126(5):e1253-e1256. Available at: http://pediatrics.aappublications.org/content/126/5/e1253.full. Accessed August 16, 2018.
Richter E, Brown-Elliott BA, Wallace Jr. RJ. Mycobacterium: Laboratory characteristics of slowly growing mycobacteria. In: Versalovic J, Carroll KC, Funke G, et al. Manual of Clinical Microbiology, 10th ed. Washington, DC: ASM Press; 2011:503-524.
Russell DG, Cardona PJ, Kim MJ, et al. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. September 2009;10(9):943-948. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759071/. Accessed August 16,2018.
Udwadia ZF. MDR, XDR, TDR tuberculosis: ominous progression. Thorax [serial online]. 2012; 67(4). Available at: http://thorax.bmj.com/content/67/4/286.extract. Accessed August 16, 2018.
Udwadia ZF, Amale RA, Ajbani KK, et al. Totally drug-resistant tuberculosis in India [correspondence]. Clin Infect Dis. 2012; 54(4):579-581. Available at: http://cid.oxfordjournals.org/content/54/4/579.long. Accessed August 16, 2018.
Udwadia ZF. Totally drug-resistant tuberculosis in India: Who let the djinn out? [editorial]. Respirology 2012;17:741-742.
Woods GL, Lin S-Y G, Desmond EP. Susceptibility test methods: Mycobacteria, Nocardia, and other Actinomycetes. In: Versalovic J, Carroll KC, Funke G, et al. Manual of Clinical Microbiology, 10th ed. Washington, DC: ASM Press; 2011:1215-1238.
World Health Organization (WHO). Tuberculosis. World Health Organization. http://www.who.int/tb/en/. 2017. Accessed September 4, 2018.